September 12, 2019
Partner Kristi Wolff
was quoted in the Natural Products Insider
article “FTC warns more CBD marketers over disease claims.” The article discusses the FTC’s letters to three CBD marketers over claims that their products can treat or cure serious diseases and health conditions. The FTC warned the companies that it is illegal to advertise such products as able to cure, prevent or treat a disease without scientific evidence.
CBD, a cannabis derived product which can be used in a multitude of forms, has steadily risen in popularity. While the FDA has only approved CBD usage for two rare forms of epilepsy, many continue to tout its ability to help ease symptoms of diseases like Alzheimer’s, cancer and anxiety, among others. The claims addressed in the FTC’s letters resemble those targeted in joint letters sent by FDA and FTC in March 2019, and in prior FDA warning letters.
“The focus of the concern isn’t new,” Wolff said. “But, further enforcement could indicate the agency has made CBD health claims more of a priority as consumers have turned to CBD to address a multitude of issues. I won’t be that surprised if we see some FTC settlements involving CBD products and health claims in the short term.”
To read the full article, click here